EUVIMEDEUVIMED entdecken
VergleichsstudieEvaluationsstudieOpen Access · CC BY 4.0

Comparison of ceftobiprole 5 μg disk diffusion, MIC test strip, and broth microdilution for susceptibility testing of Staphylococcus aureus clinical isolates

Xinying Wang iD, Yujing Tian iD, Yan Jin iD, Shujing Sui iD, Zhijun Zhang iD

Journal of Clinical Microbiology · 08.04.2026 · 64 (4)

DOI: 10.1128/jcm.00125-26 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Clinical Microbiology, erschienen am 08.04.2026. Verfasst von Xinying Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, The Affiliated Taian City Central Hospital of Qingdao University, Taian, China. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Staphylococcus aureus, Cephalosporins. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Shandong Provincial Medical and Health Science and Technology Projects, Shandong Provincial Natural Science Foundation Project, the Jinan Clinical Medical Science and Technology Innovation Plan Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ceftobiprole is a new-generation cephalosporin with activity against Staphylococcus aureus, but a comprehensive evaluation of MIC Test Strip (MTS) and disk diffusion (DD) methods using EUCAST and FDA breakpoint is lacking. Using broth microdilution (BMD) as the reference standard, we assessed the performance of MTS and DD for determining ceftobiprole susceptibility among 422 clinical S. aureus isolates. Ceftobiprole retained potent activity, with MIC₅₀/MIC₉₀ of 0.5/1 mg/L and an overall susceptibility rate of 98.8%; methicillin-resistant Staphylococcus aureus (MRSA) showed 97.6% susceptibility. MTS demonstrated high agreement with BMD, achieving 98.8% categorical agreement (CA), 1.2% major error (ME), and zero very major error (VME) under European Committee on Antimicrobial Susceptibility Testing (EUCAST) criteria, meeting the acceptability limits of ISO 20776-2:2021 and CLSI M52. DD performance was breakpoint-dependent: under EUCAST criteria, the overall CA was 89.6%, with 10.6% ME and 0 VME. The 40.3% of MRSA that fell into the EUCAST-defined Area of Technical Uncertainty (ATU) zone were all shown to be susceptible by the reference BMD method. Under Food and Drug Administration (FDA) breakpoints, the CA rose to 94.1% and ME fell to 1.7%. Consequently, MTS offers a reliable routine option; DD is suitable for routine testing under FDA breakpoints, while for EUCAST users, MRSA isolates in the ATU zone should be confirmed by BMD or MTS. VME was not determined under FDA breakpoints due to the absence of resistant isolates. IMPORTANCE Ceftobiprole offers a β-lactam option for Staphylococcus aureus , including methicillin-resistant Staphylococcus aureus (MRSA); however, its susceptibility testing remains insufficiently examined across both European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Food and Drug Administration (FDA) interpretive criteria. We systematically compared MIC Test Strip (MTS) and disk diffusion (DD) with broth microdilution (BMD), demonstrating breakpoint-specific performance for methicillin-susceptible Staphylococcus aureus (MSSA) and MRSA and providing practical recommendations that allow laboratories to report accurate results regardless of the guidelines they follow.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsStaphylococcus aureusCephalosporinsHumansMicrobial Sensitivity TestsStaphylococcal InfectionsThird Generation CephalosporinsMethicillin-Resistant Staphylococcus aureusDisk Diffusion Antimicrobial Tests

Stichwörter der Autor:innen

MIC Test StripMRSAStaphylococcus aureusbroth microdilutionceftobiproledisk diffusionmethodology

Substanzen

ceftobiproleAnti-Bacterial AgentsCephalosporinsThird Generation Cephalosporins

Autor:innen und Institutionen

  • Department of Laboratory Medicine, The Affiliated Taian City Central Hospital of Qingdao University, Taian, China.
  • Shandong Provincial Key Medical and Health Laboratory of Anti-Drug Resistant Drug Research, The Affiliated Taian City Central Hospital of Qingdao University, Taian, China.
  • Department of Laboratory Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Shandong Provincial Hospital, Jinan, China.
  • Department of Gastroenterology, The Affiliated Taian City Central Hospital of Qingdao University, Taian, China.

ORCID-Profile: Xinying Wang, Yujing Tian, Yan Jin, Shujing Sui, Zhijun Zhang

Förderung

  • the Shandong Provincial Medical and Health Science and Technology Projects
  • Shandong Provincial Natural Science Foundation Project
  • the Jinan Clinical Medical Science and Technology Innovation Plan Project

Zitieren

APA

Wang, X., Tian, Y., Jin, Y., Sui, S., & Zhang, Z. (2026). Comparison of ceftobiprole 5 μg disk diffusion, MIC test strip, and broth microdilution for susceptibility testing of Staphylococcus aureus clinical isolates. Journal of Clinical Microbiology, 64(4). https://doi.org/10.1128/jcm.00125-26

Vancouver

Wang X, Tian Y, Jin Y, Sui S, Zhang Z. Comparison of ceftobiprole 5 μg disk diffusion, MIC test strip, and broth microdilution for susceptibility testing of Staphylococcus aureus clinical isolates. Journal of Clinical Microbiology. 2026;64(4). doi:10.1128/jcm.00125-26

BibTeX
@article{Wang2026,
  author = {Wang, Xinying and Tian, Yujing and Jin, Yan and Sui, Shujing and Zhang, Zhijun},
  title = {Comparison of ceftobiprole 5 μg disk diffusion, MIC test strip, and broth microdilution for susceptibility testing of Staphylococcus aureus clinical isolates},
  journal = {Journal of Clinical Microbiology},
  year = {2026},
  volume = {64},
  number = {4},
  doi = {10.1128/jcm.00125-26}
}
Kostenlos starten →